Marex Group’s Cumberland Pharmaceuticals CPIX Stock Holding History

Marex Group’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-36,423	Closed	-$118K	–	1180
2026 Q1	$118K	Buy	+36,423	New	+$140K	﹤0.01%	940

Other funds holding CPIX

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Marex Group's CPIX Position: Q2 2026 in Review

Marex Group sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2026, closing a stake of 36,423 shares — an estimated $118K sold.

Marex Group first reported a position in CPIX in Q1 2026 and held it in 1 quarter. The position peaked at $118K in Q1 2026. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

Marex Group reported no remaining Cumberland Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Marex Group sold 36,423 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $118K.
Marex Group first reported a position in Cumberland Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Marex Group's Cumberland Pharmaceuticals position peaked at $118K in Q1 2026.
32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Marex Group's 13F filing for Q2 2026, filed 14 Aug 2026.